The MarketReader Minute
💊 CureVac Soars on BioNTech Buyout; Insmed Slides on \$750M Offering, While Moderna Faces Vaccine Policy Shake-Up | Biotech Sector Insights
(IBB) has seen a slight increase of 0.1% since Wednesday. Notably, among the ETF's holdings, significant contributors to performance included AMGN, BNTX, GILD, CVAC, and CRL.